Mineralys Therapeutics, Inc.
USD25.97
-0.91 (-3.39%)
CEO
Jon Congleton
IPO Date
2023-02-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$26.82
Prev. Close
$26.88
Day Low
$25.56
Day High
$26.85
52W Low
$12.59
52W High
$47.65
Market Cap
$1.72B
Volume
0.50M
| 9,890 |
| $23.81 |
| 17 Jun 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 4,167 | $14.25 |
| 17 Jun 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 417 | $15.44 |
| 17 Jun 2026 | Rodman David Malcom | Chief Medical Officer | S-Sale | Disposed | 4,584 | $25.00 |
| 17 Jun 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Disposed | 3,542 | $10.20 |
| 17 Jun 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Disposed | 4,167 | $14.25 |
| 17 Jun 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Disposed | 417 | $15.44 |
| 17 Jun 2026 | Karydas Daphne | director | M-Exempt | Acquired | 3,000 | $12.02 |
| 17 Jun 2026 | Karydas Daphne | director | S-Sale | Disposed | 3,000 | $25.00 |